Literature DB >> 18327782

Synovial sarcoma presenting as a parotid mass: case report and review of literature.

Amrita Jay1, Iain Hutchison, Kim Piper, Paula M Farthing, Polly S Richards.   

Abstract

BACKGROUND: Synovial sarcoma is an unusual neoplasm of mesenchymal derivation, which is uncommon in the head and neck sites. In the parotid gland, it is most likely to be misdiagnosed as a myoepithelial, primary mesenchymal, or metastatic neoplasm.
METHODS: We report a case of synovial sarcoma in a young woman who was seen with temporomandibular joint symptoms with a 10-year history. A review of the literature was undertaken to highlight the radiologic and histologic features that help in diagnosis as well as the suggested therapeutic protocols most likely to ensure better survival.
RESULTS: Radiologic and histologic studies of the parotid mass led to a diagnosis of synovial sarcoma. A total parotidectomy was performed, and the individual remains tumor free at 36 months.
CONCLUSIONS: Review of the literature suggests an aggressive long-term outcome for synovial sarcoma and advocates early diagnosis and radical surgical excision for a favorable prognosis. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18327782     DOI: 10.1002/hed.20822

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

Review 1.  Synovial sarcoma of the parotid gland: a case report and review of the literature.

Authors:  M Rigante; M Visocchi; G Petrone; A Mulè; F Bussu
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-12-29       Impact factor: 2.124

2.  [Excellent response to external radiotherapy of a primary synovial sarcoma of the parotid gland].

Authors:  Amal Asabbane; Issam Lalya; Ilham Lalya; Tayeb Kebdani; Khalid Hassouni; Jean-Michel Coindre; Brahim Khalil El-Gueddari; Noureddine Benjaafar
Journal:  Pan Afr Med J       Date:  2011-03-30

3.  Tumor size predicts prognosis of head and neck synovial cell sarcoma.

Authors:  Alimujiang Wushou; Xin-Chao Miao
Journal:  Oncol Lett       Date:  2014-10-24       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.